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Patients with congenital heart diseases (CHD) are confronted with 
early- and late-onset complications, such as conduction disorders, 
arrhythmias, myocardial dysfunction, altered coronary flow, and 
ischemia, throughout their lifetime despite successful hemodynamic 
and/or anatomical correction. Rhythm disturbance is a well-known 
and increasingly frequent cause of morbidity and mortality in 
patients with CHD. Predisposing factors to rhythm disturbances 
include underlying cardiac defects, hemodynamic changes as 
part of the natural history, surgical repair and related scarring, 
and residual hemodynamic abnormalities. Acquired factors such 
as aging, hypertension, diabetes, obesity, and others may also 
contribute to arrhythmogenesis in CHD. The first step in evaluating 
arrhythmias in CHD is to understand the complex anatomy and 
to find predisposing factors and hemodynamic abnormalities. A 
practical stepwise approach can lead to diagnosis and prompt 
appropriate interventions. Electrophysiological assessment and 
management should be done with integrated care of the underlying 
heart defects and hemodynamic abnormalities. Catheter ablation 
and arrhythmia surgery have been increasingly applied, showing 
increasing success rates with technological advancement despite 
complicated arrhythmia circuits in complex anatomy and the difficulty 
of access. Correction of residual hemodynamic abnormalities may be 
critical in the treatment of arrhythmia in patients with CHD.
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Introduction
Survival of patients having congenital heart disease (CHD) has 
remarkably improved with rapid advances in medical and surgical 
treatments. This has brought a new population of adult CHD 
cases and increasing incidence of late-onset complications, such as 
heart failure or rhythm disturbances, during the patients’ lifetime 
regardless of successful hemodynamic and anatomical correction. 
Rhythm disturbances in CHD are well-known complications 
that could occur throughout lifetime and may be life threatening. 
They can cause serious hemodynamic compromise and sudden 
cardiac death in patients with CHD. Individuals with CHD may 
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have a different conduction system from those with a structurally 
normal heart due to errors in embryologic development. 
Arrhythmias in CHD may interact with multiple aspects of the 
disease, including underlying abnormalities, patient age, type and 
results of surgical procedure, and age at surgery. Surgical scar and 
residual hemodynamic problems are important factors that increase 
the risk of arrhythmia. Acquired factors may also increase the risk 
of arrhythmias in CHD. The mechanism of rhythm disturbances 
in CHD is multiform; they require substrates, triggers, and 
maintenance factors. Reentry is known as the most common 
mechanism of arrhythmias in CHD. Diagnosis should be based 
on all factors affecting arrhythmogenesis in CHD. A practical 
approach to rhythm disturbances could be helpful for clinicians 
to obtain proper diagnosis and treatment. A simple stepwise 
approach will be discussed, and an illustrative case will be shown, 
to demonstrate the application of this simple stepwise method to 
rhythm disturbances in CHD.  
Prevalence and relative risk of arrhythmias in CHD
The prevalence of supraventricular and/or ventricular 
arrhythmias is recently reported to be 18%
1). With the increasing 
number of grown-up CHD cases, rhythm disturbance has become 
more important in the cardiac management of CHD. Arrhythmias 
most likely occur at an advanced age.
The prevalence of late-onset atrial flutter or atrial fibrillation 
in atrial septal defect (ASD) increases progressively with aging, 
more so in patients who underwent surgery after 11 years of age 
and patients over the age of 40
2-4). Rhythm disturbances in ASD 
have much do to with longstanding volume overload on the 
right heart, compounded by tricuspid regurgitation, pulmonary 
arterial hypertension, and heart failure. However, the left atrial 
and pulmonary venous involvement is thought to be involved in 
the arrhythmogenesis of ASD because the success rate of maze 
operation for atrial fibrillation was higher than the modified right-
size maze procedure in restoring and maintaining sinus rhythm 
after ASD closure
5). The transcatheter closure of ASDs may 
possibly reduce the risk of atrial arrhythmia if done at a younger 
age, if treated at smaller defects, and because of the absence of 
surgical scars, which themselves may act as a reentrant circuit for 
arrhythmia. Transcatheter closure of ASD has been reported to 
have a low risk of late atrial arrhythmias in patients who underwent 
procedure at less than 55 years old
6). 
Ventricular tachycardia after repair of tetralogy of Fallot (TOF) 
can serve as a paradigm for postoperative ventricular tachycardia 
in the CHD population. Reentry is known to be the main 
mechanism of arrhythmia, which circulates around the scar or 
patch in the right ventricular outflow tract
7). Long-lasting pressure 
overload of the right ventricle and long-standing hypoxemia 
could contribute to pathologic changes such as cardiomyocytic 
degeneration and interstitial fibrosis, which have been implicated 
in myocardial dysfunction and ventricular arrhythmias
8). The risk 
factors of ventricular tachycardia in repaired TOF are as follows: 
moderate or severe pulmonary regurgitation, history of sustained 
ventricular tachycardia, moderate or severe left ventricular 
dysfunction, prolonged QRS duration more than 180 ms, and 
rapid change of QRS duration
9-15). In patients with repaired TOF, 
sustained ventricular tachycardia and sudden cardiac death are 
reported to be 11.9% and 8.3%, respectively, with incidence 
per decade of sudden death of 1.2-3.0%
16-19). Pulmonary valve 
replacement reduces right ventricular size and stabilizes QRS 
duration; however, substantial reduction in the incidence of 
subsequent monomorphic ventricular tachycardia is controversial
20, 
21). Although often less dramatic than ventricular arrhythmias 
in terms of hemodynamic complications, atrial arrhythmias 
are almost equally as frequent in repaired TOF
9, 22). The risk of 
supraventricular tachycardia in repaired TOF is reported to be 
minimal until QRS duration becomes more than 160 ms
23). 
In patients who underwent the Fontan procedure, preoperative 
and postoperative risk factors should be considered in dealing 
with rhythm disturbances. Preoperative risk factors include 
atrioventricular valve regurgitation, older age at operation, poor 
preoperative functional status, previous atrial septectomy, and 
preoperative atrial tachyarrhythmia
24-26). Postoperatively, surgery-
related factors should be considered, such as pulmonary artery 
reconstruction, atriopulmonary anastomosis, early postoperative 
atrial tachyarrhythmia, and postoperative sinus node dysfunction. 
Efforts to decrease long-term complications such as arrhythmias 
have brought several modifications to the Fontan operation, with 
consequent reduction of incidence of arrhythmias
27-29). 
Specific arrhythmias and associated defects can be divided into 
2 parts: tachycardia and bradycardia. Supraventricular tachycardias 
occur in 30-50% of patients after atrial switch operation for 
complete transposition of the great arteries (TGA)
30). Intra-
atrial reentrant tachycardia (IART) is common in postoperative 
Mustard, Senning, and Fontan operations. Atrial fibrillation in 
mitral valve diseases, aortic stenosis, and unrepaired functional 
single ventricle may also occur. An accessory pathway is common 
in Ebstein anomaly and corrected TGA
31, 32). The incidence of 
supraventricular tachycardias in Ebstein anomaly is reported to 
be 40-80%
33). Twin atrioventricular (AV) node can be present 
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supraventricular tachycardias commonly develop with an incidence 
of 30-60%
24, 25, 34). The most common tachyarrhythmia in repaired 
TOF is supraventricular tachycardia, the incidence of which is 
reported to be up to 35%
16, 33). Ventricular tachycardia is well 
known in repaired TOF and congenital aortic stenosis. Even in 
repaired ASD or repaired VSD, late arrhythmia could occur with 
the incidence of 5-15% in ASD and less than 2% in VSD
34, 35).
In bradycardia, sinoatrial node (SA) node dysfunction can be 
present in heterotaxy syndrome (left isomerism: polysplenia) or 
from damage in postoperative Mustard, Senning, and Fontan 
operations. The AV node can also be naturally blocked in corrected 
TGA and AV septal defect (AVSD), and can be damaged after 
surgical repair of ventricular septal defect (VSD), subaortic stenosis, 
and AV valve replacement. 
The relative risk for specific arrhythmias in CHD depends on 
the underlying congenital heart defect (Table 1)
36). Ventricular 
tachycardia or sudden cardiac death is much more common in 
TOF, aortic stenosis, and atrial switch-operated complete TGA. 
Scar-related atrial tachycardias can develop in almost all CHD 
cases with atrial scars, but are more common in atrial switch-
operated complete TGA and Fontan-operated single ventricle. 
Accessory pathways are commonly noted in corrected TGA and 
Ebstein anomaly. Long after atria switch operation (Mustard or 
Senning operation) for complete TGA, IART and sinus node 
dysfunction are commonly noted. Fontan operation is known to 
have a high incidence of sinus node dysfunction. AV conduction 
abnormality is high in corrected TGA and AVSD.   
Clinical implication of cardiac conduction 
development in the congenital heart malformations
Assessment of conduction abnormalities in congenital heart 
malformations should begin by understanding the events that 
occur during the development of the conduction system in 
the prenatal and/or postnatal period
37). During embryological 
development, sinus node and AV node form cardiac chambers. 
Errors in the control of cardiac development may lead to a heart 
with a mirror-image position, which is called situs inversus; 
abnormal location of sinus node and AV node, which is common 
in corrected TGA and AVSD; and dual or absent sinus node 
and atriovenricular node, which are common in atrial isomerism 
(asplenia or polysplenia). After completion of inflow and outflow 
of both ventricles, normal ventricular conduction system is 
also completed. Abnormal heart development could lead to an 
abnormal conduction system. The conduction system also changes 
with aging.
Substrates for rhythm disturbances in CHD 
Substrates for rhythm disturbances can be investigated in terms 
of the subcomponents of the cardiac conduction system. The 
pacemaker component has a sinus node that could be injured 
congenitally or by surgery. In the slow impulse conduction 
component, atrial conduction abnormalities and AV node damage 
could develop. Twin AV node, abnormal location of AV node, 
and accessory pathway can also be present. In the rapid impulse 
conduction component, the His-Purkinje system can be damaged. 
These functional and anatomical abnormalities can be substrates 
for reentry arrhythmias. Accessory pathways and twin AV nodes 
are also related to arrhythmias (Table 2). 
Predisposing factors and acquired factors to 
arrhythmias in CHD 
The risk of arrhythmias in CHD is different from that in a 
structurally normal heart. Many predisposing and acquired factors 
Table 1. Comparison of Relative Risk of Rhythm Disturbances in Congenital Heart Diseases
IART AF WPW
VT
SCD
Sinus node 
dysfunction
Spontaneous
AV Block
Traumatic 
AV Block
VSD
ASD
TOF
AS
Complete TGA (s/p atrial  switch op)
AVSD
SV s/p Fontan op
Corrected TGA
Ebstein anomaly
+
+ 
++ 
+++ 
+ 
+++ 
+ 
++
+ 
+ 
+ 
++ 
+++
+ 
++ 
++ 
++ 
+ 
+ 
+++ 
+++ 
+ 
++ 
+ 
+ 
++ 
+++ 
Abbreviations: AF, atrial fibrillation; WPW, Wolff-Parkinson-White syndrome; SCD, sudden cardiac death; VSD, ventricular septal defect; ASD, atrial septal defect; 
TOF, tetralogy of Fallot; AS, aortic stenosis; TGA, transposition of the great arteries; AVSD, atrioventricular septal defect; SV s/p Fontan op, single ventricle after 
the Fontan operation; +++, high risk; ++,  moderate risk; and +, low risk; atrial switch op, Mustard or Senning operation  
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are involved in the arrhythmogenesis. Genetic and anatomical 
predispositions, such as congenital anomaly, are the underlying 
factors of arrhythmias. 
  Hemodynamic changes by internal and external stressors, such 
as heart failure, ischemia, cyanosis, hypertension, and infarction, 
may act as substrates for arrhythmias. Surgical scar and residual 
problems are also involved. Subsequent structural and electrical 
remodeling could stabilize arrhythmia with the help of iatrogenic 
factors such as electrolytes and/or medications.
 Acquired factors like aging, hypertension, diabetes, obesity, 
and others may play important roles in arrhythmogenesis in 
CHD. Many factors influence rhythm disturbances throughout 
lifetime. Hemodynamic conditions could be influenced not only 
by underlying anatomical defect but also by acquired valvular and 
ventricular dysfunction. Aging is a well-known contributing factor 
for arrhythmogenesis of atrial fibrillation
38). Aging can also affect 
the cardiovascular system of CHD patients
39-41). Other common 
lifetime problems are coronary heart disease, hypertension, 
diabetes, and obesity (Table 3).  
Practical approach to arrhythmia in CHD 
The availability of a simple method to diagnose rhythm 
disturbances in CHD is very helpful for the clinician. This 
stepwise approach to rhythm disturbances in CHD can be applied 
based on the basic understanding of the cardiac conduction 
system. Using the cardiac conduction system subcomponents as 
the basis, each step should evaluate several points encompassing 
anatomy, conduction, hemodynamic conditions, surgery, and 
acquired factors. First check point should be the pacemaker 
component, evaluating if the sinus node works properly at its 
normal location. The second step should be assessing the atrial 
conduction of slow impulse conduction component. Third, the AV 
node function in the slow impulse conduction component should 
be checked, looking at whether the accessory pathway or twin AV 
node is present. Fourth, the rapid impulse conduction component 
should be evaluated in terms of the status of the His-Purkinje 
system. Finally, the risk of arrhythmias and sudden cardiac death, 
hemodynamic status, and need for surgical intervention should be 
assessed (Table 4). 
Table 2. Substrates for Rhythm Disturbances in Congenital Heart 
Diseases 
Pacemaker component
       Sinus node damage
Slow impulse conduction component
     Intraatrial or interatrial conduction delay
             Congenital/acquired 
     AV node 
             damage (congenital/ acquired)
             dual (twin) AV node/ abnormal location
     Accessory pathways
Rapid impulse conduction components
     His-Purkinje system damage 
            Congenital /acquired
Table 3. Factors Influencing Arrhythmogenesis in Congenital Heart 
Diseases influencing 
Predisposing factors    
Underlying cardiac defect 
      - e.g. atrial isomerism, corrected TGA, Ebstein anomaly
      - e.g. sinus node dysfunction, accessory pathway, twin AV node
Hemodynamic changes as part of the natural history 
      - e.g. chamber enlargement, myocardial fibrosis
Surgical repair and scarring 
      - e.g. ventricle scar, atrial scar, patch, baffle 
Residual postoperative hemodynamic abnormalities 
    - e.g. pressure or volume overload
    - e.g. severe pulmonary regurgitation in repaired TOF
Acquired factors
Hemodynamic change - acquired
     - ventricular function
     - valvular function
Aging
Coronary heart disease
Hypertension
Diabetes, Obesity, etc
Table 4. Stepwise Approach to Arrhythmias according to Sub­
components of the Cardiac Conduction System 
Step 1 - Pacemaker component
Sinus node node
Congenital – atrial isomerism
Acquired –surgical damage 
Step 2 - Slow impulse conduction component
Atrium conduction delay
Congenital / acquired
Step 3 - Slow impulse conduction component
Atrioventricular(AV) node 
Congenital / acquired 
Accessory pathway 
Corrected TGA, Ebstein anomaly
Dual (twin) AV node
Step 4 - Rapid impulse conduction component
His-Purkinje system damage 
Congenital / acquired
Step 5 - Risk stratification
Atrial arrhythmia
Fontan procedure
Ventricular arrhythmia 
s/p ventriculotomy 
Risk of sudden cardiac death  
Hemodynamic condition 
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Clinical assessment of arrhythmias in CHD:           
an illustrative case of repaired TOF 
Fig. 1 shows an example of a stepwise approach to risk 
stratification of arrhythmias in CHD. This patient is an adult case 
with repaired TOF. By assessing predisposing and acquired factors, 
the total risk of arrhythmia in this repaired TOF case can be 
evaluated step by step, as follows: 
Step 1: Underlying congenital defect is TOF without accessory 
pathway or conduction problems.
Step 2: Hemodynamic changes as part of the natural history 
of TOF are hypertrophy of the right ventricle and longstanding 
cyanosis.
Step 3: Surgical repair and scarring in repaired TOF are present 
in the right atrium and right ventricle.
Step 4: Residual postoperative hemodynamic abnormalities are 
severe pulmonary regurgitation and residual pulmonary stenosis.
Step 5: In addition to those factors, acquired factors also 
contribute to the development of arrhythmias.
Then, according to the subcomponents of cardiac conduction 
system, a stepwise approach to specific diagnosis of arrhythmias 
can be done as follows:  
Step 1, for the pacemaker component: His SA node looks 
normal.
Step 2, for atrium of the slow conduction component: He has 
dilated atrium and surgical scar.
Step 3, for AV node of the slow conduction component: He 
has normal AV node conduction and low probability of accessory 
pathway.
Step 4, for the rapid conduction component: Left ventricle is 
normal in volume and function, but right ventricle is dilated with 
severe pulmonary regurgitation and surgical scar.  
Step 5, for risk stratification: He has several risk factors, such as 
older age at initial repair, prolonged QRS duration of more than 
180 ms, and severe pulmonary regurgitation. 
From the above information, we can conclude that this patient 
has high risk of atrial and ventricular arrhythmia and presumptive 
diagnosis of clinically significant tachycardia supported by history 
of palpitation. Finally, the decision for an approgriate treatment, 
whether the patient needs electrophysiologic study, should be 
made. The patient seems to need surgery for poor pulmonary 
valve function, causing severe RV volume load. Therefore, 
electrophysiology study and catheter ablation, if needed, should 
be performed before surgery. Concomitant arrhythmia surgery or 
ICD implantation may be recommended if ventricular tachycardia 
is documented.
Schematic approach to electrophysiologic study 
and treatment of supraventricular tachycardia/
ventricular tachycardia in CHD 
The schematic approach to the electrophysiologic study with 
catheter ablation in supraventricular arrhythmias in CHD is 
shown in Fig. 2. For surpaventricular arrhythmias in CHD, 
the assessment of hemodynamic condition is very important. 
Medication may be the first line of treatment in some patients. 
Patients are divided into 5 groups: The first group is composed of 
patients who did not undergo surgery and do not need surgical 
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corrections such as small ASD. Electrophysiologic study with 
catheter ablation is recommended without closure of ASD. ASD 
closure is not indicated for the treatment of arrhythmia. The second 
group includes patients who did not undergo surgery but need 
repair of defects such as large ASD or Ebstein anomaly. In ASD, 
device closure can be done concomitantly with electrophysiologic 
study and catheter ablation. The third group includes patients who 
had open heart surgery and have atrial scars. The fourth group 
includes Ebstein anomaly, corrected TGA, and isomerism showing 
high incidence of accessory pathway, conduction abnormality, and 
twin AV node. Electrophysiologic study with catheter ablation is 
also recommended for these 2 groups. If there are any surgically 
correctable hemodynamic problems, electrophysiologic study 
with catheter ablation should be performed before surgery and 
concomitant arrhythmia surgery also should be considered. 
Electrophysiologic study with catheter ablation is also performed 
for ventricular tachycardia occurring after repair of CHD (Fig. 
2). In patients with RV scar after repair of CHD who have long 
QRS duration of more than 180 ms, severe dilated RV, and history 
of ventriculotomy, additional risk factors such as high ventricle 
end diastolic pressure (LVEDP) and nonsustained ventricular 
tachycardia can prompt the electrophysiologic study and catheter 
ablation before the replacement of pulmonary valve. Ventricular 
tachycardia from systemic or single ventricle can develop in 
patients with CHD. However, there are no confirmed risk factors. 
Ventricular dysfunction and hemodynamic compromise during 
Fig. 2. Practical approach to the management of supraventricular tachycardias in congenital 
heart disease.
Fig. 3. Practical approach to the management of ventricular tachycardia in congenital heart 
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ventricular tachycardia are the most important factors in deciding 
invasive electrophysiologic intervention with/or without ICD 
implantation. Through electrophysiologic study, the necessity 
of ICD or concomitant arrhythmia surgery for the primary 
prevention of sudden cardiac death should be evaluated.    
Conclusion
In the assessment of rhythm disturbances in CHD, predispos-
ing and acquired factors should be evaluated, looking at the 
development of the conduction system in congenital heart 
malformations. A stepwise approach could help clinicians to easily 
obtain the proper diagnosis and suggest appropriate treatments. 
Correction of residual hemodynamic abnormalities may be critical 
in the treatment of arrhythmia in CHD. The electrophysiological 
assessment and management should be done with integrated care 
of the underlying heart defects and hemodynamic abnormalities.
For the growing population of CHD patients, future studies 
should focus on minimizing the potential substrates for rhythm 
disturbances and on finding early aggressive treatments. 
Prevention of other cardiovascular diseases related to aging, such 
as coronary artery disease, hypertension, and others, should also be 
emphasized. 
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